Michael Seewald

Michael is a biochemist by education. During his academic career he has built deep skills in analytical disciplines (biophysics, bioinformatics, chemoinformatics) while addressing key questions around human biology and disease pathology. He has authored and co-authored publications in leading journals such as Nature and EMBO J.

When Michael began his industry career, he was leading cross-functional teams in research, heading Bayer Pharma´s bioinformatics efforts, and proposing new targets for pharmaceutical research. Subsequently, Michael transitioned through roles in Finance, Strategy, Marketing, building general management skills and deep knowledge of value generation across the life cycle of healthcare innovations. At Novartis, Michael is heading the Center of Excellence for Real World Evidence.